Vertex Pharmaceuticals has grown from a $7.5 billion market cap to over $120 billion as it’s commercialized several products.

Gene editing technologies have cemented their place as a valued method in the biological toolkit used by researchers around the globe.

The Cell Shuttle was designed to help academic cell therapy developers by providing an integrated, automated solution.

Three PhD scholars from Jamia Millia Islamia’s MCARS have started postdoctoral research in the USA, reflecting strong ...